GPP
ALXN

Great Point Partners’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Great Point Partners’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-110,506
Closed -$13.7M – 39
2018
Q2 		$13.7M Buy
+110,506
New +$13.7M 1.9% 17